secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001493152-23-046163
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences enters exchange agreements for Series F-1 Preferred Stock in connection with Aditxt merger
--------------------------------------------------------------------------------

- Evofem exchanged certain rights and warrants with holders for 22,280 shares of new Series F-1 Convertible Preferred Stock.
- The exchange agreements were executed on Dec 21, 2023, following the merger agreement with Aditxt signed on Dec 11, 2023.
- Holders agreed to waive change of control redemption rights related to the merger in exchange for new rights and preferred stock.
- The Series F-1 Preferred Stock will later be exchanged for Aditxt preferred stock prior to merger consummation.
- The exchange was exempt from registration under Section 3(a)(9) of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223046163/0001493152-23-046163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223046163/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-046163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer